We are transforming once-discarded birth byproducts into powerful, pharmaceutical-grade regenerative therapies. Eradicating disease at the cellular level, rather than endlessly managing symptoms.
11,000 sqft cGMP/AATB facility, FDA registered and inspected.
Manufacturing placental membrane patches — placental-derived exosome and stem cell products for regenerative therapeutics.
Our Mission is to bring a new biologic paradigm to allopathic medical treatments for improved patient outcomes in a wide spectrum of medical and surgical pathologies, without side effects or adverse events, and high levels of patient successful outcomes.
Compliant with full cGMP and cGTP standards, supported by a robust and comprehensive quality system, and licensed in all applicable states requiring certification. FDA registered and inspected, AATB accredited.
